practices & industries professionals offices newsroom careers about us

O’Melveny Awards US$160,000 in Scholarships to LAUSD Students
May 20, 2013

O'Melveny Further Bolsters Global Restructuring Practice
May 17, 2013

O’Melveny’s Pearl, Ehlers Author Article for Competition Policy International
May 15, 2013

Search Results

Practice: Pharmaceuticals
News Type: Press Releases, Media Coverage

Press Releases
O’Melveny Represents Progenics Pharmaceuticals in its Acquisition of Molecular Insight Pharmaceuticals	January 22, 2013
O’Melveny Represents Independent Committee in ShangPharma Corporation Going Private Transaction	January 8, 2013
O’Melveny Represents Alta Partners in Investment in Zafgen, Inc.	December 4, 2012
O’Melveny Represents Nektar Therapeutics in Private Placement of US$125 Million in Senior Secured Notes	July 10, 2012
O’Melveny Represents Alliance Health Networks in Acquisition of Medify	May 16, 2012
O’Melveny Adds Ross Galin to Health Care and Life Sciences & White Collar Practices	April 10, 2012

Media Coverage
O’Melveny’s Representation of Progenics Pharmaceuticals in its Acquisition of Molecular Insight Reported in Daily Journal	January 25, 2013
O'Melveny’s Representation of Alta Partners in Investment Covered in Multiple Media Outlets	December 5, 2012
O’Melveny’s Deaton Quoted in Scrip Intelligence on Self-Reporting FCPA Violations	August 9, 2012
O’Melveny’s Representation of Pharmaceutical Company in Shareholder Action Noted in Law360	July 30, 2012
O’Melveny’s Appointment as Legal Advisor to ShangPharma Reported by Marketwatch	July 17, 2012
O’Melveny Named to Novartis’ Preferred Legal Program	July 17, 2012
O’Melveny’s Representation of Venturepharma in PE Deal with CVC Asia Pacific Ltd. Noted in Asia Deal Digest	May 7, 2012
Multiple Outlets Report on Stanton Lovenworth Joining O’Melveny	April 20, 2012
Multiple Outlets Report on Addition of Ross Galin to O’Melveny	April 13, 2012
O’Melveny Addition of Galin to Health Care and Life Sciences & White Collar Practices Featured in Bloomberg Businessweek	April 12, 2012
O'Melveny's Victory for Allergan in Botox Trade Secrets Case Covered by Several Media Outlets	March 8, 2012
O'Melveny Lawyers Co-Author Article on Constitutionality of Regulatory Ban on Off-Label Marketing	February 17, 2012
O'Melveny's Zucker Comments on Proposed Abbott Labs Breakup For The Deal Pipeline	October 20, 2011
O'Melveny's Zucker Discusses Government Efforts to Spur Biomedical Innovation in Daily Journal Article	October 20, 2011
O’Melveny’s Representation of Matrixx Noted in Bloomberg BusinessWeek, Law360	March 23, 2011

	Search
Site Newsroom Advanced